U.S. market Closed. Opens in 6 hours 47 minutes

KRON | Kronos Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue6.29MN/AN/AN/AN/AN/A
Cost of RevenueN/A4.46M4.08M4.87M605.00K160.00K
Gross Profit6.29M-4.46M-4.08M-4.87M-605.00K-160.00K
Operating Expenses128.12M137.12M151.40M58.04M16.82M6.64M
Selling, General & Admin41.74M43.40M38.49M14.79M3.37M1.61M
Research & Development86.38M93.72M112.90M43.25M13.45M5.03M
Other Operating ExpensesN/AN/AN/A-27.41MN/AN/A
Operating Income-121.83M-137.12M-151.40M-58.04M-16.82M-6.64M
Other Expenses / Income9.16M3.91M320.00K-30.40M699.00K-76.00K
Before Tax Income-112.67M-133.20M-151.08M-88.44M-16.12M-6.72M
Income Tax ExpensesN/A-3.91M-1.98M-24.36M-699.00K-70.14K
Net Income-112.67M-129.29M-149.10M-64.09M-15.42M-6.72M
Interest ExpensesN/AN/AN/A3.89MN/A76.00K
Basic Shares Outstanding57.74M56.20M54.75M54.07M53.04M28.45M
Diluted Shares Outstanding57.74M56.20M54.75M54.07M53.04M28.45M
EBITDA-119.69M-128.74M-147.00M-79.69M-15.51M-6.49M
EBITDA Margin-1,903.53%0.00%0.00%0.00%0.00%0.00%
EBIT-112.67M-133.20M-151.08M-84.55M-16.12M-6.72M
EBIT Margin-1,791.87%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙